作者
Xilin Zhao, Karl Drlica
发表日期
2001/9/15
来源
Clinical Infectious Diseases
卷号
33
期号
Supplement_3
页码范围
S147-S156
出版商
The University of Chicago Press
简介
Studies with fluoroquinolones have led to a general method for restricting the selection of antibiotic-resistant mutants. The strategy is based on the use of antibiotic concentrations that require cells to obtain 2 concurrent resistance mutations for growth. That concentration has been called the “mutant prevention concentration” (MPC) because no resistant colony is recovered even when >1010 cells are plated. Resistant mutants are selected exclusively within a concentration range (mutant selection window) that extends from the point where growth inhibition begins, approximated by the minimal inhibitory concentration, up to the MPC. The dimensions of the mutant selection window can be reduced in a variety of ways, including adjustment of antibiotic structure and dosage regimens. The window can be closed to prevent mutant selection through combination therapy with ≥2 antimicrobial agents if their …
引用总数
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202483633313446303834282234283530241921181420193